Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.

Duits LC, Phoa KN, Curvers WL, Ten Kate FJ, Meijer GA, Seldenrijk CA, Offerhaus GJ, Visser M, Meijer SL, Krishnadath KK, Tijssen JG, Mallant-Hent RC, Bergman JJ.

Gut. 2014 Jul 17. pii: gutjnl-2014-307278. doi: 10.1136/gutjnl-2014-307278. [Epub ahead of print]

PMID:
25034523
[PubMed - as supplied by publisher]
2.

The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.

Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR.

Am J Gastroenterol. 2000 Dec;95(12):3383-7.

PMID:
11151865
[PubMed - indexed for MEDLINE]
3.

Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus.

Kastelein F, Biermann K, Steyerberg EW, Verheij J, Kalisvaart M, Looijenga LH, Stoop HA, Walter L, Kuipers EJ, Spaander MC, Bruno MJ; ProBar-study group.

Gut. 2013 Dec;62(12):1676-83. doi: 10.1136/gutjnl-2012-303594. Epub 2012 Dec 20.

PMID:
23256952
[PubMed - indexed for MEDLINE]
4.

Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.

Kastelein F, van Olphen S, Steyerberg EW, Sikkema M, Spaander MC, Looman CW, Kuipers EJ, Siersema PD, Bruno MJ, de Bekker-Grob EW; on behalf of the ProBar-study group.

Gut. 2014 Jul 18. pii: gutjnl-2014-307197. doi: 10.1136/gutjnl-2014-307197. [Epub ahead of print]

PMID:
25037191
[PubMed - as supplied by publisher]
5.

[Barrett's oesophagus: endoscopic diagnosis and follow-up].

Ponsot P.

Ann Chir. 2006 Jan;131(1):3-6. Epub 2005 Dec 1. Review. French.

PMID:
16376849
[PubMed - indexed for MEDLINE]
6.

Risk Stratification of Patients With Barrett's Esophagus and Low-grade Dysplasia or Indefinite for Dysplasia.

Thota PN, Lee HJ, Goldblum JR, Liu X, Sanaka MR, Gohel T, Kanadiya M, Lopez R.

Clin Gastroenterol Hepatol. 2014 Aug 4. pii: S1542-3565(14)01095-7. doi: 10.1016/j.cgh.2014.07.049. [Epub ahead of print]

PMID:
25102445
[PubMed - as supplied by publisher]
7.

Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.

Kerkhof M, van Dekken H, Steyerberg EW, Meijer GA, Mulder AH, de Bruïne A, Driessen A, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD; CYBAR study group.

Histopathology. 2007 Jun;50(7):920-7.

PMID:
17543082
[PubMed - indexed for MEDLINE]
8.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

PMID:
16545207
[PubMed - indexed for MEDLINE]
Free Article
9.

Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.

Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P.

Gastroenterology. 2011 Oct;141(4):1179-86, 1186.e1. doi: 10.1053/j.gastro.2011.06.055. Epub 2011 Jun 30.

PMID:
21723218
[PubMed - indexed for MEDLINE]
10.

Low-grade dysplasia in Barrett's esophagus has a high risk of progression.

Lim CH, Treanor D, Dixon MF, Axon AT.

Endoscopy. 2007 Jul;39(7):581-7.

PMID:
17611911
[PubMed - indexed for MEDLINE]
11.

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.

Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML, Hart J.

Hum Pathol. 2001 Apr;32(4):379-88.

PMID:
11331954
[PubMed - indexed for MEDLINE]
12.

Risk for Esophageal Neoplasia in Barrett's Esophagus Patients with Mucosal Changes Indefinite for Dysplasia.

Horvath B, Singh P, Xie H, Thota PN, Allende DS, Pai RK, Patil DT, Plesec TP, Goldblum JR, Liu X.

J Gastroenterol Hepatol. 2014 Aug 4. doi: 10.1111/jgh.12696. [Epub ahead of print]

PMID:
25087917
[PubMed - as supplied by publisher]
13.

Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years.

Hage M, Siersema PD, van Dekken H, Steyerberg EW, Dees J, Kuipers EJ.

Scand J Gastroenterol. 2004 Dec;39(12):1175-9.

PMID:
15742992
[PubMed - indexed for MEDLINE]
14.

Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.

Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE.

Am J Gastroenterol. 1997 Nov;92(11):2012-6.

PMID:
9362182
[PubMed - indexed for MEDLINE]
15.

The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.

den Hoed CM, van Blankenstein M, Dees J, Kuipers EJ.

Br J Cancer. 2011 Jul 12;105(2):200-5. doi: 10.1038/bjc.2011.214. Epub 2011 Jun 14.

PMID:
21673678
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.

Srivastava A, Hornick JL, Li X, Blount PL, Sanchez CA, Cowan DS, Ayub K, Maley CC, Reid BJ, Odze RD.

Am J Gastroenterol. 2007 Mar;102(3):483-93; quiz 694.

PMID:
17338734
[PubMed - indexed for MEDLINE]
17.

Consistency of a high-grade dysplasia diagnosis in Barrett's oesophagus: a Dutch nationwide cohort study.

Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, van Baal JW, Siersema PD.

Dig Liver Dis. 2014 Apr;46(4):318-22. doi: 10.1016/j.dld.2013.11.010. Epub 2013 Dec 30.

PMID:
24388501
[PubMed - in process]
18.

Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.

van Sandick JW, Baak JP, van Lanschot JJ, Polkowski W, ten Kate FJ, Obertop H, Offerhaus GJ.

J Pathol. 2000 Feb;190(2):177-83.

PMID:
10657016
[PubMed - indexed for MEDLINE]
19.

Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.

Ayers K, Shi C, Washington K, Yachimski P.

Surg Endosc. 2013 Aug;27(8):2836-40. doi: 10.1007/s00464-013-2830-x. Epub 2013 Feb 7.

PMID:
23389078
[PubMed - indexed for MEDLINE]
20.

The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?

Meining A, Ott R, Becker I, Hahn S, Mühlen J, Werner M, Höfler H, Classen M, Heldwein W, Rösch T.

Gut. 2004 Oct;53(10):1402-7.

PMID:
15361485
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk